U.S. Representative Billy Long has introduced legislation to update regulations guiding how drug manufacturers communicate product information.
U.S. Representative Billy Long (R-MO 7th District) has introduced legislation to update regulations guiding how drug manufacturers communicate product information. Long is the lead sponsor of H.R. 2479, which would ensure the FDA clearly regulated meaningful, truthful and non-misleading communication of product information on social media.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.